Limiting Pharma’s Scope Three Emissions: A Strategic Imperative

By ACG

The pharmaceutical industry is thought to be the world’s biggest polluter, with latest research concluding that it is less climate friendly than the automotive sector. Explore how CDMOs can support your firm reduce Scope 3 emissions, limit toxic waste production and better protect the environment in this whitepaper from ACG Pharma.

Enter your details below to view the free white paper

By downloading this whitepaper, you acknowledge that GlobalData may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how GlobalData may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.